Biotech Values

[RockRat]

"Since FDA approval, sales that may be presumed to be tax-related, at least in
part, have been made by Wheeler, Venkataraman, Brugger, and Bishop
at prices between 17.20 and 24.48. "

I'm not seeing any change in Bishop's position in the three tables you've recently posted.

Not that it's a big deal.

Regards, RockRat